Jul 28, 2026 06:21AM
Jul 28, 2026 06:15AM
Jul 13, 2026 04:05PM
Jul 13, 2026 04:05PM
Jul 10, 2026 11:49AM
Jun 29, 2026 01:59AM
Jun 29, 2026 01:59AM AB Science reports completion of the step 3 of phase 1, evaluating the combination of AB8939 with venetoclax for the treatment of refractory or relapsed AML
Jun 17, 2026 12:04PM
Jun 10, 2026 04:05PM
Jun 10, 2026 04:05PM
Jun 9, 2026 12:47PM
Jun 2, 2026 12:05PM
May 25, 2026 12:06PM
May 13, 2026 01:36PM AB Science reports its revenues for the year 2025 and provides an update on its activities
May 11, 2026 04:05PM
Apr 28, 2026 06:16AM
Apr 28, 2026 06:15AM
Apr 27, 2026 12:06PM
Apr 20, 2026 03:37PM
Apr 20, 2026 03:32PM
Apr 16, 2026 01:20PM AB Science provides an update on its clinical development program.
Apr 13, 2026 04:05PM
Mar 11, 2026 04:05PM
Feb 24, 2026 12:02PM
Feb 11, 2026 04:05PM
Feb 5, 2026 06:22AM
Feb 5, 2026 06:20AM
Jan 29, 2026 12:01PM AB Science receives US patent approval for masitinib cancer treatment
Jan 29, 2026 12:00PM
Jan 21, 2026 12:02PM
Jan 12, 2026 04:05PM
Jan 7, 2026 12:03PM
Jan 7, 2026 12:02PM
Dec 22, 2025 11:57AM
Dec 18, 2025 01:17PM AB Science announces the initiation of coverage of its stock by Maxim Group with a target price of EUR 4.0 per share
Dec 15, 2025 12:39PM
Dec 11, 2025 12:29PM
Dec 10, 2025 04:07PM
Dec 10, 2025 04:05PM
Nov 11, 2025 04:05PM
Nov 11, 2025 04:05PM
Oct 23, 2025 06:21AM AllianceBernstein (AB) Tops Q3 EPS by 1c
Oct 23, 2025 06:20AM
Oct 16, 2025 02:58PM
Oct 16, 2025 02:57PM
Oct 14, 2025 02:36AM
Oct 14, 2025 02:36AM
Oct 10, 2025 12:10PM
Oct 9, 2025 04:05PM AB Announces September 30, 2025 Assets Under Management
Sep 30, 2025 12:32PM

1,216,155 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All